Navigating an executive leadership change? Use our eBook to facilitate a smooth transition. Download Now

Westicke Partners

Close

Inari Medical, Inc.

$179 Million Initial Public Offering

Inari Medical, Inc.

In May 2020, ICR Westwicke began an engagement with Inari Medical, Inc., a commercial-stage medical device company, to assist the company with its IPO. After much preparation and an exceptionally successful four-day virtual roadshow, Inari shares closed up 124% on the first day of trading. That first-day trading performance ranks #1 among MedTech IPOs of the last decade.

Download the case study for more details on how ICR Westwicke’s guidance led to the highest file/offer performance for a healthcare IPO since 2015.

Clinical trial data disclosure can be tricky.

Download our checklist of 10 disclosure guidelines to minimize risk and maximize the impact of good news.

Download Now

Our Locations